Supplementary Methods from Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells During Prostate Cancer Metastasis

Marcus Ruscetti,Bill Quach,Eman L. Dadashian,David J. Mulholland,Hong Wu

DOI: https://doi.org/10.1158/0008-5472.22405847

2023-01-01

Abstract:Supplementary Methods. Description of additional methods and procedures used in the study.

What problem does this paper attempt to address?

Supplementary Figure S3 from Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells During Prostate Cancer Metastasis

Marcus Ruscetti,Bill Quach,Eman L. Dadashian,David J. Mulholland,Hong Wu

DOI: https://doi.org/10.1158/0008-5472.22405856

2023-01-01

Abstract:Supplementary Figure S3. EMT-like and mesenchymal tumor cells have enhanced tumor-initiating capacity in vivo.
Supplementary Methods and References from MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer

Su Li,Yongli Luo,Yang Liu,Jing Yang,Chao Yao,Cheng Fang,Juanjuan Shan,Jun Chen,Fangfang Li,Limei Liu,Chungang Liu,Yong Xu,Lupin Jiang,Deyu Guo,Jesús Prieto,Matías A. Ávila,Junjie Shen,Cheng Qian

DOI: https://doi.org/10.1158/0008-5472.22412124.v1

2023-01-01

Abstract:Description of additional methods and procedures used in the study. Also includes Supplementary References.
Supplementary Methods from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Rajat Bhattacharya,Xiang-Cang Ye,Rui Wang,Xia Ling,Madonna McManus,Fan Fan,Delphine Boulbes,Lee M. Ellis

DOI: https://doi.org/10.1158/0008-5472.22407989.v1

2023-01-01

Abstract:Description of additional methods and procedures used in the study.
Supplementary Figure Legends from Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells During Prostate Cancer Metastasis

Marcus Ruscetti,Bill Quach,Eman L. Dadashian,David J. Mulholland,Hong Wu

DOI: https://doi.org/10.1158/0008-5472.22405865.v1

2023-01-01

Abstract:Supplementary Figure Legends. Legend for Supplementary Figures S1-S5.
Supplementary Figures 1-2, Tables 1-8 from Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis

Xueying Mao,Yongwei Yu,Lara K. Boyd,Guoping Ren,Dongmei Lin,Tracy Chaplin,Sakunthala C. Kudahetti,Elzbieta Stankiewicz,Liyan Xue,Luis Beltran,Manu Gupta,R. Tim D. Oliver,Nick R. Lemoine,Daniel M. Berney,Bryan D. Young,Yong-Jie Lu

DOI: https://doi.org/10.1158/0008-5472.22383381.v1

2023-01-01

Abstract:Supplementary Figures 1-2, Tables 1-8 from Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis
Supplementary Methods from MEK Inhibition Modulates Cytokine Response to Mediate Therapeutic Efficacy in Lung Cancer

Mengyu Xie,Hong Zheng,Ranjna Madan-Lala,Wenjie Dai,Nicholas T. Gimbrone,Zhihua Chen,Fumi Kinose,Sarah A. Blackstone,Keiran S.M. Smalley,W. Douglas Cress,Eric B. Haura,Uwe Rix,Amer A. Beg

DOI: https://doi.org/10.1158/0008-5472.22422753

2023-01-01

Abstract:Supplementary Methods for Xie et al, MEK inhibition modulates cytokine response to mediate therapeutic efficacy in lung cancer
Supplementary Table 1 from Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases

Inna Smalley,Zhihua Chen,Manali S. Phadke,Jiannong Li,Xiaoqing Yu,Clayton Wyatt,Brittany Evernden,Jane L. Messina,Amod A. Sarnaik,Vernon K. Sondak,Chaomei Zhang,Vincent Law,Nam Tran,Arnold Etame,Robert J.B. Macaulay,Zeynep Eroglu,Peter Forsyth,Paulo C. Rodríguez,Yigiang Chen,Keiran S.M. Smalley

DOI: https://doi.org/10.1158/1078-0432.22481007.v1

2023-01-01

Abstract:Supplemental Table 1: Flow Cytometry Antibodies
Supplementary Data Legends and Methods from Novel Oncogene–Induced Metastatic Prostate Cancer Cell Lines Define Human Prostate Cancer Progression Signatures

Xiaoming Ju,Adam Ertel,Mathew C. Casimiro,Zuoren Yu,Hua Meng,Peter A. McCue,Robin G. Walters,Paolo Fortina,Michael P. Lisanti,Richard G. Pestell

DOI: https://doi.org/10.1158/0008-5472.22396404

2023-01-01

Abstract:PDF file - 132KB, Legends for Supplementary Table 1 and Figures 1-7, and Supplementary Methods
Supplementary Methods and References from Targeting the C-Met/fzd8 Signaling Axis Eliminates Patient-Derived Cancer Stem–like Cells in Head and Neck Squamous Carcinomas

Shuyang Sun,Suling Liu,Sheng Zhong Duan,Lei Zhang,Henghua Zhou,Yongjie Hu,Xianghui Zhou,Chaoji Shi,Rong Zhou,Zhiyuan Zhang

DOI: https://doi.org/10.1158/0008-5472.22403975

2023-01-01

Abstract:Supplementary Methods and References. Description of additional methods and procedures used in the study. Also includes Supplementary References.
Supplementary Table 2 from Characterization of TMPRSS2-ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer

Rohit Mehra,Scott A. Tomlins,Jianjun Yu,Xuhong Cao,Lei Wang,Anjana Menon,Mark A. Rubin,Kenneth J. Pienta,Rajal B. Shah,Arul M. Chinnaiyan

DOI: https://doi.org/10.1158/0008-5472.22374854

2023-01-01

Abstract:Supplementary Table 2 from Characterization of TMPRSS2-ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer
Supplementary Table 2 from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Junying Zeng,Sharad Sharma,Yong‐Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming-Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22503681

2023-01-01

Abstract:PDF - 79K, Supplementary Table 2. Sensitivities of L3.6pl cells, CSCs+24/44/ESA and their derived polyploid cells in response to different chemotherapeutics.
Supplementary Data - Materials and Methods from Epigenetically Regulated Chromosome 14q32 miRNA Cluster Induces Metastasis and Predicts Poor Prognosis in Lung Adenocarcinoma Patients

Margarita González-Vallinas,Manuel Rodríguez-Paredes,Marco Albrecht,Carsten Sticht,Damian Stichel,Julian Gutekunst,Adriana Pitea,Steffen Sass,Francisco J. Sánchez-Rivera,Justo Lorenzo-Bermejo,Jennifer Schmitt,Carolina De La Torre,Arne Warth,Fabian J. Theis,Nikola S. Müller,Norbert Gretz,Thomas Muley,Michael Meister,Darjus F. Tschaharganeh,Peter Schirmacher,Franziska Matthäus,Kai Breuhahn

DOI: https://doi.org/10.1158/1541-7786.22517494

2023-01-01

Abstract:Supplementary Data - Materials and Methods
Epithelial-Mesenchymal Transition: A Fundamental Cellular and Microenvironmental Process in Benign and Malignant Prostate Pathologies

Aviv Philip Goncharov,Nino Vashakidze,Gvantsa Kharaishvili

DOI: https://doi.org/10.3390/biomedicines12020418

IF: 4.757

2024-02-12

Biomedicines

Abstract:Epithelial-mesenchymal transition (EMT) is a crucial and fundamental mechanism in many cellular processes, beginning with embryogenesis via tissue remodulation and wound healing, and plays a vital role in tumorigenesis and metastasis formation. EMT is a complex process that involves many transcription factors and genes that enable the tumor cell to leave the primary location, invade the basement membrane, and send metastasis to other tissues. Moreover, it may help the tumor avoid the immune system and establish radioresistance and chemoresistance. It may also change the normal microenvironment, thus promoting other key factors for tumor survival, such as hypoxia-induced factor-1 (HIF-1) and promoting neoangiogenesis. In this review, we will focus mainly on the role of EMT in benign prostate disease and especially in the process of establishment of malignant prostate tumors, their invasiveness, and aggressive behavior. We will discuss relevant study methods for EMT evaluation and possible clinical implications. We will also introduce clinical trials conducted according to CONSORT 2010 that try to harness EMT properties in the form of circulating tumor cells to predict aggressive patterns of prostate cancer. This review will provide the most up-to-date information to establish a keen understanding of the cellular and microenvironmental processes for developing novel treatment lines by modifying or blocking the pathways.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Supplementary Tables from A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast Cancer

Mengmeng Zhang,Kaiwen Zhou,Zilin Wang,Ting Liu,Laura E. Stevens,Filipa Lynce,Wendy Y. Chen,Sui Peng,Yubin Xie,Duanyang Zhai,Qianjun Chen,Yawei Shi,Huijuan Shi,Zhongyu Yuan,Xiaoping Li,Juan Xu,Zhenhai Cai,Jianping Guo,Nan Shao,Ying Lin

DOI: https://doi.org/10.1158/0008-5472.25964561.v1

2024-01-01

Abstract:All supplementary tables in one excel file
Supplementary Table from Functional Analysis of MET Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination

Feng Wang,Yang Liu,Wanglong Qiu,Elaine Shum,Monica Feng,Dejian Zhao,Deyou Zheng,Alain Borczuk,Haiying Cheng,Balazs Halmos

DOI: https://doi.org/10.1158/0008-5472.22431033.v1

2023-01-01

Abstract:Supplementary Table from Functional Analysis of MET Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
Supplementary Methods from Mir-508 Defines the Stem-like/Mesenchymal Subtype in Colorectal Cancer

Ting-Ting Yan,Lin-Lin Ren,Chao-Qin Shen,Zhen-Hua Wang,Ya-Nan Yu,Qian Liang,Jia-Yin Tang,Ying-Xuan Chen,Dan-Feng Sun,Witold Zgodzinski,Marek Majewski,Piotr Radwan,Ilona Kryczek,Ming Zhong,Jinxian Chen,Qiang Liu,Weiping Zou,Hao-Yan Chen,Jie Hong,Jing-Yuan Fang

DOI: https://doi.org/10.1158/0008-5472.22417235

2023-01-01

Abstract:This file contains methods which were not included in the main text.
Supplementary Figures 1-7 from Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells

David J. Mulholland,Naoko Kobayashi,Marcus Ruscetti,Allen Zhi,Linh M. Tran,Jiaoti Huang,Martin Gleave,Hong Wu

DOI: https://doi.org/10.1158/0008-5472.22391619

2023-01-01

Abstract:PDF file - 1.5MB
Supplementary Methods from an Integrated Genome-Wide Approach to Discover Tumor-Specific Antigens As Potential Immunologic and Clinical Targets in Cancer

Qing-Wen Xu,Wei Zhao,Yue Wang,Maureen A. Sartor,Dong-Mei Han,Jixin Deng,Rakesh Ponnala,Jiang-Ying Yang,Qing-Yun Zhang,Guo-Qing Liao,Yi-Mei Qu,Lu Li,Fang-Fang Liu,Hong-Mei Zhao,Yan-Hui Yin,Wei-Feng Chen,Yu Zhang,Xiao-Song Wang

DOI: https://doi.org/10.1158/0008-5472.22394712

2023-01-01

Abstract:PDF file - 179K, Includes HEPA analysis data, Calculation of DP score, and supplementary references
Supplementary Data from The Tumor Suppressor Smad4 Is Required for Transforming Growth Factor β–Induced Epithelial to Mesenchymal Transition and Bone Metastasis of Breast Cancer Cells

Martine Deckers,Maarten van Dinther,Jeroen Buijs,Ivo Que,Clemens Löwik,Gabri van der Pluijm,Peter ten Dijke

DOI: https://doi.org/10.1158/0008-5472.22366088.v1

2023-01-01

Abstract:Supplementary Methods, Figures 1-3 and Table 1

Supplementary Methods from Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells During Prostate Cancer Metastasis

Supplementary Figure S3 from Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells During Prostate Cancer Metastasis

Supplementary Methods and References from MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer

Supplementary Methods from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Supplementary Figure Legends from Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells During Prostate Cancer Metastasis

Supplementary Figures 1-2, Tables 1-8 from Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis

Supplementary Methods from MEK Inhibition Modulates Cytokine Response to Mediate Therapeutic Efficacy in Lung Cancer

Supplementary Table 1 from Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases

Supplementary Data Legends and Methods from Novel Oncogene–Induced Metastatic Prostate Cancer Cell Lines Define Human Prostate Cancer Progression Signatures

Supplementary Methods and References from Targeting the C-Met/fzd8 Signaling Axis Eliminates Patient-Derived Cancer Stem–like Cells in Head and Neck Squamous Carcinomas

Supplementary Table 2 from Characterization of TMPRSS2-ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer

Supplementary Table 2 from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Supplementary Data - Materials and Methods from Epigenetically Regulated Chromosome 14q32 miRNA Cluster Induces Metastasis and Predicts Poor Prognosis in Lung Adenocarcinoma Patients

Epithelial-Mesenchymal Transition: A Fundamental Cellular and Microenvironmental Process in Benign and Malignant Prostate Pathologies

Supplementary Tables from A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast Cancer

Supplementary Table from Functional Analysis of MET Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination

Supplementary Methods from Mir-508 Defines the Stem-like/Mesenchymal Subtype in Colorectal Cancer

Supplementary Figures 1-7 from &lt;i&gt;Pten&lt;/i&gt; Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells

Supplementary Methods from an Integrated Genome-Wide Approach to Discover Tumor-Specific Antigens As Potential Immunologic and Clinical Targets in Cancer

Supplementary Data from The Tumor Suppressor Smad4 Is Required for Transforming Growth Factor β–Induced Epithelial to Mesenchymal Transition and Bone Metastasis of Breast Cancer Cells

Supplementary Figures 1-7 from <i>Pten</i> Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells